ARCHIVES

Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research

This article is from The Cancer Letter archive.

Vol. 24 No. 04 | January 30, 1998

Download PDF Visit The Full Archive

Related Articles

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

CREG Announcement June 1 Includes 17 Projects Worth $4.1 Million

May 16, 1975

NCAB Discussion Of Working Group Report

February 28, 2003

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013

Letter: The Lesson From Dana-Farber

July 28, 1995

NCI Moves Ahead With Trials Database, Reporting Studies In Progress At Cancer Centers

July 15, 2011